|
Real-time
Euronext Paris
02:52:09 11/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1.980 EUR | +5.32% |
|
+3.39% | -26.94% |
| 01/10 | Taconic Biosciences, Inc. And genOway Partner To Expand U.S. Access To Advanced Humanized Mouse Models | CI |
| 23/09 | GenOway teams up with Taconic Biosciences to accelerate in the United States |
| Market Cap | 1.73Cr 1.93Cr 1.6Cr 1.45Cr 2.75Cr 181.22Cr 2.82Cr 19Cr 7.62Cr 97Cr 7.25Cr 7.1Cr 306.94Cr | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 2.41Cr 2.68Cr 2.22Cr 2.01Cr 3.81Cr 251.46Cr 3.92Cr 27Cr 11Cr 134.72Cr 10Cr 9.85Cr 425.9Cr | EV / Sales 2024 |
1.36x | EV / Sales 2025 | 1.22x |
| Free-Float |
59.02% | Yield 2024 * |
-
| Yield 2025 | - |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALGEN | Real-time | |
| JEH | Delayed | ||
| JEH | Real-time | ||
| JEH | Delayed |
| 1 day | +5.32% | ||
| 1 week | +3.39% | ||
| Current month | -4.35% | ||
| 1 month | -10.81% | ||
| 3 months | -20.80% | ||
| 6 months | -21.43% | ||
| Current year | -26.94% |
| 1 week | 1.81 | 2.02 | |
| 1 month | 1.81 | 2.26 | |
| Current year | 1.81 | 2.79 | |
| 1 year | 1.81 | 2.88 | |
| 3 years | 1.81 | 4.91 | |
| 5 years | 1.81 | 4.91 | |
| 10 years | 1 | 7.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Operating Officer | - | 01/03/1999 | |
Benjamin Bruneau
DFI | Director of Finance/CFO | - | 01/10/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 01/03/1999 | |
| Chairman | - | - | |
Laurent Fraisse
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/01/22 | Buy | Chief Executive Officer | 12,500 | 0.1376% | ||
| 17/11/21 | Sell | Chief Executive Officer | 5,000 | 0.0553% | ||
| 13/11/21 | Sell | Founder | 1,147 | 0.0127% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +5.32% | +3.39% | -15.74% | -51.94% | 1.93Cr | ||
| +0.01% | +11.10% | +60.83% | +70.43% | 6.83TCr | ||
| +0.72% | +6.77% | +14.11% | +89.13% | 6.03TCr | ||
| +0.09% | 0.00% | +19.68% | +97.14% | 5.59TCr | ||
| +1.60% | +19.44% | +28.80% | +112.95% | 4.84TCr | ||
| -1.32% | +4.78% | +29.15% | +40.40% | 4.53TCr | ||
| -3.54% | -0.60% | +207.76% | +879.50% | 4.18TCr | ||
| -3.33% | +6.90% | +22.78% | +48.07% | 3.45TCr | ||
| -1.26% | -1.20% | +84.21% | +56.55% | 3.38TCr | ||
| -1.49% | +1.16% | +47.05% | +0.16% | 2.6TCr | ||
| Average | -0.33% | +3.89% | +49.86% | +134.24% | 4TCr | |
| Weighted average by Cap. | -0.68% | +5.25% | +53.96% | +152.59% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.58Cr 2.88Cr 2.38Cr 2.16Cr 4.09Cr 270.18Cr 4.21Cr 29Cr 11Cr 144.75Cr 11Cr 11Cr 457.61Cr | 2.6Cr 2.9Cr 2.4Cr 2.18Cr 4.12Cr 272.14Cr 4.24Cr 29Cr 11Cr 145.8Cr 11Cr 11Cr 460.92Cr |
| Net income | 18.31L 20.41L 16.87L 15.32L 29L 19Cr 29.81L 2.02Cr 80.49L 10Cr 76.61L 74.99L 32Cr | 9L 10.35L 9L 8L 14.7L 9.7Cr 15.11L 1.02Cr 40.79L 5.2Cr 38.82L 38L 16Cr |
| Net Debt | 6L 7L 6L 5L 10L 6.51Cr 10.14L 68.74L 27.39L 3.49Cr 26.07L 25.52L 11Cr | 67.18L 74.91L 61.91L 56.23L 1.06Cr 70Cr 1.09Cr 7.41Cr 2.95Cr 38Cr 2.81Cr 2.75Cr 118.96Cr |
Employees
163
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | €1.980 | +5.32% | 2,351 |
| 10/26/10 | €1.880 | -1.05% | 19,604 |
| 09/26/09 | €1.900 | -3.80% | 20,183 |
| 06/26/06 | €1.975 | -1.00% | 3,699 |
| 05/26/05 | €1.995 | +4.18% | 8,820 |
- Stock Market
- Stocks
- ALGEN Stock
Select your edition
All financial news and data tailored to specific country editions
















